Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
2018 · New England Journal of Medicine · 2,782 citations
https://doi.org/10.1056/nejmoa1716153
Y
Yoshiki Sekijima
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
435
Papers
14.2K
Citations
50
h-index
164
i10-index
Yoshiki Sekijima is an academic researcher from Shinshu University. The author has contributed to research in topics: Amyloidosis: Diagnosis, Treatment, Outcomes & Parathyroid Disorders and Treatments & Alzheimer's disease research and treatments. The author has an h-index of 50, co-authored 370 publications.
ORCID: 0000-0002-8132-2743Papers by this author
worksDiagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm
2018 · Orphanet Journal of Rare Diseases · 146 citations
https://doi.org/10.1186/s13023-017-0726-x
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
2022 · Orphanet Journal of Rare Diseases · 82 citations
https://doi.org/10.1186/s13023-022-02359-w
Rapid and comprehensive diagnostic method for repeat expansion diseases using nanopore sequencing
2022 · npj Genomic Medicine · 75 citations
https://doi.org/10.1038/s41525-022-00331-y
Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis
2021 · JACC Heart Failure · 67 citations
https://doi.org/10.1016/j.jchf.2021.05.005
Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatment
2023 · The Lancet Neurology · 51 citations
https://doi.org/10.1016/s1474-4422(23)00334-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat